8-K/A

AMENDMENT NO. 1

Company: Emmaus Life Sciences, Inc.
Filed: October 8, 2003
Period of Report: May 22, 2003
Accession Number: 0001144204-03-006140

View Document ↗ View on SEC.gov ↗